BECN1 and neoplasm: Loss of Beclin 1 expression defines poor prognosis by promoting anti-apoptotic pathways, whereas overexpression of Beclin 1, being linked with tumor hypoxia and acidity, also defines subgroups of tumors with aggressive clinical behavior [29].